PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 58 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $118,000 | -62.3% | 89,300 | -11.2% | 0.00% | – |
| Q3 2021 | $313,000 | +11.8% | 100,566 | +20.6% | 0.00% | – |
| Q4 2020 | $280,000 | -53.7% | 83,400 | -36.6% | 0.00% | -100.0% |
| Q2 2020 | $605,000 | +12.0% | 131,500 | -19.4% | 0.00% | 0.0% |
| Q1 2020 | $540,000 | +130.8% | 163,200 | +190.4% | 0.00% | – |
| Q3 2019 | $234,000 | – | 56,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|